Trial intelligence / Profile preview

Vitamin C for POAF Prevention in Egyptian CABG Patients

NCT06074367Phase 4Unknown

Sponsor
Helwan University
Start
Oct 2020
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ascorbic acid in Atrial fibrillation (AFib), sponsored by Helwan University. Status: unknown.

02

Drugs

ascorbic acid
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT06074367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06074367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call